Hudson Value Partners’s Idexx Laboratories IDXX Stock Holding History

Hudson Value Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-300	Closed	-$205K	–	109
2025 Q4	$205K	Sell	300 -50	-14%	-$34.1K	0.06%	107
2025 Q3	$224K	Buy	+350	New	+$212K	0.07%	106

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hudson Value Partners's IDXX Position: Q1 2026 in Review

Hudson Value Partners sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 300 shares — an estimated $205K sold.

Hudson Value Partners first reported a position in IDXX in Q3 2025 and held it in 2 quarters. The position peaked at $224K in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Hudson Value Partners reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Hudson Value Partners sold 300 Idexx Laboratories shares in Q1 2026, an estimated $205K.
Hudson Value Partners first reported a position in Idexx Laboratories in Q3 2025 and held it in 2 quarters.
Hudson Value Partners's Idexx Laboratories position peaked at $224K in Q3 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Hudson Value Partners's 13F filing for Q1 2026, filed 14 Apr 2026.